‎Jamjoom Pharma provides SAR 31.8M corporate guarantee to its JV in Algeria

‎Jamjoom Pharma provides SAR 31.8M corporate guarantee to its JV in Algeria ‎Jamjoom Pharma provides SAR 31.8M corporate guarantee to its JV in Algeria

​‎

Jamjoom Pharma said the purpose of the banking facility is to fund Jamjoom Algeria’s mid-term working capital requirements

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) announced that its 49%-owned joint venture in Algeria, Jamjoom Algeria Lil Dawa SPA, signed a Standby Letter of Credit (SBLC) offer with NATIXIS ALGERIE with a total value of DZD 2.25 billion equivalent to approximately SAR 64.89 million.

Advertisement

In a statement to Tadawul, the company said that to support the issuance of this SBLC, the company has provided a corporate guarantee to the bank on Jan. 15, 2026 in accordance with Algerian Law and in proportion to the company’s shareholding in the JV.

Therefore, the company will be guaranteeing DZD 1.102 billion corresponding to approximately SAR 31.795 million.

The purpose of the banking facility is to fund Jamjoom Algeria’s mid-term working capital requirements.

The statement also noted that Jamjoom Algeria is a related party, as the company’s board members, Mahmoud Jamjoom and Ahmed Jamjoom, have a direct interest due to their membership on the board of Jamjoom Algeria. Meanwhile, the members Walid Jamjoom, Mohammed Jamjoom, and Alaa Jamjoom have an indirect interest.

 

Jamjoom Pharma said the purpose of the banking facility is to fund Jamjoom Algeria’s mid-term working capital requirements

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) announced that its 49%-owned joint venture in Algeria, Jamjoom Algeria Lil Dawa SPA, signed a Standby Letter of Credit (SBLC) offer with NATIXIS ALGERIE with a total value of DZD 2.25 billion equivalent to approximately SAR 64.89 million.

In a statement to Tadawul, the company said that to support the issuance of this SBLC, the company has provided a corporate guarantee to the bank on Jan. 15, 2026 in accordance with Algerian Law and in proportion to the company’s shareholding in the JV.

Therefore, the company will be guaranteeing DZD 1.102 billion corresponding to approximately SAR 31.795 million.

The purpose of the banking facility is to fund Jamjoom Algeria’s mid-term working capital requirements.

The statement also noted that Jamjoom Algeria is a related party, as the company’s board members, Mahmoud Jamjoom and Ahmed Jamjoom, have a direct interest due to their membership on the board of Jamjoom Algeria. Meanwhile, the members Walid Jamjoom, Mohammed Jamjoom, and Alaa Jamjoom have an indirect interest.

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement